Published:
|
|
Is there any treatment?
There is no standard treatment for iniencephaly since most infants rarely live longer than a few hours. Medicine is based more on prevention using supplementation with folic acid. Numerous studies have demonstrated that mothers can reduce the risk of neural tube birth defects such as iniencephaly by
up to 70 percent with daily supplements of at least 4 mg of folic acid. Pregnant women should avoid taking antiepileptic drugs, diuretics, antihistamines, and sulfa drugs, which have been shown
to be associated with an increased risk of neural tube defects. Maternal obesity and diabetes are also known to increase the risk for these disorders.
What is the prognosis?
The prognosis for infants with iniencephaly is extremely poor. Newborns seldom survive much past childbirth. The distortions of the baby’s body also pose a danger to the mother's life during delivery.
What research is being done?
The National Institute of Neurological Disorders and Stroke (NINDS) and other institutes of the National Institutes of Health
(NIH) conduct research related to iniencephaly in laboratories at the NIH and also support additional research through grants
to major medical institutions across the country. Much of this research explores the complex mechanisms of neural tube development.
The knowledge gained from these fundamental studies will provide a foundation for developing ways to prevent iniencephaly
and the other neural tube defects.